Literature DB >> 33783969

Clinical parameters and biomarkers predicting spontaneous operational tolerance after liver transplantation: A scoping review.

Christian Appenzeller-Herzog1, Steffen Hartleif2, Julien Vionnet3,4,5.   

Abstract

Indefinite allograft acceptance after immunosuppression withdrawal (ISW), also known as operational tolerance (OT), can occur spontaneously after liver transplantation (LT), but reliable and reproducible prognosis of OT versus non-OT outcomes remains elusive. To prime this, systematic extraction of OT-predictive factors from the literature is crucial. We provide the first comprehensive identification and synthesis of clinical parameters and biomarkers predicting spontaneous OT in non-autoimmune/non-replicative viral LT recipients selected for ISW. We searched Embase, Medline, the Cochrane Central Register of Controlled Trials, clinicaltrials.gov, and the World Health Organization International Clinical Trials Registry Platform for articles, conference abstracts, and ongoing trials. We contacted principal investigators of stand-alone abstracts and ongoing trials for unpublished data and screened citations and references of eligible articles. Twenty-three articles reporting on 11 completed ISW studies, 13 abstracts, and five trial registry entries were included. Longer time between LT and ISW was the only clinical parameter that may increase the incidence of OT. Prognostic biomarkers conspicuously differed between pediatric and adult ISW candidates. These included allograft gene expression patterns and peripheral blood immune exhaustion markers for adults, and histological allograft scores for children. Our results will foster cross-validation efforts to facilitate safe and harmonized candidate selection for successful ISW.
© 2021 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  biomarker; clinical decision-making; clinical research/practice; health services and outcomes research; immunobiology; immunosuppression/immune modulation; immunosuppressive regimens - minimization/withdrawal; liver allograft function/dysfunction; liver transplantation / hepatology; tolerance

Mesh:

Substances:

Year:  2021        PMID: 33783969     DOI: 10.1111/ajt.16585

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  1 in total

Review 1.  Revisiting transplant immunology through the lens of single-cell technologies.

Authors:  Arianna Barbetta; Brittany Rocque; Deepika Sarode; Johanna Ascher Bartlett; Juliet Emamaullee
Journal:  Semin Immunopathol       Date:  2022-08-18       Impact factor: 11.759

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.